COMPANY PROFILE // THE 014 REPORT
Xtant Medical Holdings, Inc.
XTNT (NYSE) · Formerly: Bacterin International Holdings, Inc.; K KITZ INC
Assembled from 3 government sources in 0.3 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberLEI 549300JOU6AK8387EW77 registration status is LAPSED (last update 2026-08-12): the legal-entity record has not been renewed.
- InfoGLEIF: no direct parent reported; reporting exception reason NON_CONSOLIDATING.
✓ SEC filings✓ LEI✓ SAM registrationpossible match✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No IRS return, no state registration, no website, no lobbying registration on record.
Xtant Medical Holdings, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Belgrade, MT; listed as XTNT (NYSE).[source] It reported revenue of $133.9 million for the fiscal year ended 2025-12-31.[source] It has filed 33 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are Nantahala Capital Management, LLC, AWM Investment Company, Inc., VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 1 item from these records: LEI 549300JOU6AK8387EW77 registration status is LAPSED (last update 2026-08-12).[source]
- red0
- amber1
- info1
- Nantahala Capital Management, LLC$57.6M
- AWM Investment Company, Inc.$2.5M
- VANGUARD CAPITAL MANAGEMENT LLC$848K
- RENAISSANCE TECHNOLOGIES LLC$394K
- GEODE CAPITAL MANAGEMENT, LLC$218K
- Crescent Grove Advisors, LLC$173K
- NANO CAP NEW MILLENNIUM GROWTH FUND L P$168K
- VANGUARD FIDUCIARY TRUST CO$109K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Browne Sean E · President and CEO (Director,Officer) · latest Form 4 2025-11-18 · filing · LinkedIn search
- Neils Scott C · CFO and Assistant Secretary (Officer) · latest Form 4 2026-01-16 · filing · LinkedIn search
- Schallenberger Mark A. · Chief Operating Officer (Officer) · latest Form 4 2026-02-18 · filing · LinkedIn search
- BAKEWELL JOHN K · Director · latest Form 4/A 2025-11-18 · filing · LinkedIn search
- Beeson Jonn R. · Director · latest Form 4 2025-11-18 · filing · LinkedIn search
- JAIN ABHINAV · Director · latest Form 4 2025-11-18 · filing · LinkedIn search
- Lipschultz Tyler · Director · latest Form 4 2025-11-18 · filing · LinkedIn search
- Vizirgianakis Stavros G. · Director · latest Form 4 2025-11-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Links
- Official website (Wikidata or the SEC record)
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001453593 | source |
| LEI | 549300JOU6AK8387EW77 | source |
| UEIpossible match | JN7YZJBMVPD4 | source |
| CAGEpossible match | 7JTP2 | source |
| EIN | 20-5313323 | source |
| Business address (SEC) | 664 CRUISER LANE, BELGRADE, MT, 59714 | source |
Does not exist in the records we hold: NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2019-08-11 · in -2,660 days · LEI next renewal (549300JOU6AK8387EW77)
- 2027-01-07 · in 46 days · SAM registration expires (UEI JN7YZJBMVPD4)possible match
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
ADDRESS · ZIP CODE
Location context
Federal contractors nearby in the same code (1)
- XTANT MEDICAL HOLDINGS, INC. · SAM Active
registered in SAM.gov with the same ZIP code (59714) and the same primary NAICS code (339113), extract 2026-11-01
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- AYTU BIOPHARMA, INC · JAIN ABHINAV
- Apyx Medical Corp · Vizirgianakis Stavros G.
- TALPHERA, INC. · JAIN ABHINAV
- TREACE MEDICAL CONCEPTS, INC. · BAKEWELL JOHN K
EVERY SOURCE · NEWEST FIRST
One timeline
- 2027-01-07 registration SAM registration expiry (UEI JN7YZJBMVPD4) · SAM.gov
- 2026-11-16 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-16 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-07 filing 8-K items 5.07,9.01 · SEC EDGAR
- 2026-06-23 filing ARS · SEC EDGAR
- 2026-06-23 filing DEFA14A · SEC EDGAR
- 2026-06-23 filing Proxy statement · SEC EDGAR
- 2026-05-29 filing SD · SEC EDGAR
- 2026-05-13 filing S-8 POS · SEC EDGAR
- 2026-05-13 filing S-8 POS · SEC EDGAR
- 2026-05-13 filing S-8 POS · SEC EDGAR
- 2026-05-13 filing S-8 POS · SEC EDGAR
- 2026-05-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-13 filing 8-K items 2.02,8.01,9.01 · SEC EDGAR
- 2026-04-13 filing 8-K items 7.01,8.01,9.01 · SEC EDGAR
- 2026-03-31 filing Annual report (10-K) · SEC EDGAR
- 2026-03-31 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-03-02 filing 8-K items 8.01 · SEC EDGAR
- 2026-01-16 filing 8-K items 8.01 · SEC EDGAR
- 2025-12-03 filing 8-K items 2.01,2.04,7.01,9.01 · SEC EDGAR
- 2025-11-18 insider First Form 3/4/5 on record for Schallenberger Mark A. (Chief Operating Officer) · SEC Forms 3/4/5
- 2025-11-18 insider First Form 3/4/5 on record for BAKEWELL JOHN K (Director) · SEC Forms 3/4/5
- 2025-11-18 insider First Form 3/4/5 on record for Beeson Jonn R. (Director) · SEC Forms 3/4/5
- 2025-11-18 insider First Form 3/4/5 on record for Vizirgianakis Stavros G. (Director) · SEC Forms 3/4/5
- 2025-11-10 filing S-8 · SEC EDGAR
- 2025-11-10 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-11-10 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-10 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
170 earlier entries
- 2025-09-15 filing ARS
- 2025-09-15 filing DEFA14A
- 2025-09-15 filing Proxy statement
- 2025-08-19 insider First Form 3/4/5 on record for Browne Sean E (President and CEO)
- 2025-08-19 insider First Form 3/4/5 on record for Neils Scott C (CFO and Assistant Secretary)
- 2025-08-12 filing Quarterly report (10-Q)
- 2025-08-12 filing 8-K items 2.02,7.01,9.01
- 2025-08-08 filing 8-K items 8.01
- 2025-08-08 insider First Form 3/4/5 on record for JAIN ABHINAV (Director)
- 2025-08-08 insider First Form 3/4/5 on record for Lipschultz Tyler (Director)
- 2025-08-05 filing SCHEDULE 13D/A
- 2025-08-04 officer change 8-K items 5.02,9.01
- 2025-07-08 filing 8-K items 1.01,7.01,8.01,9.01
- 2025-05-30 filing SD
- 2025-05-20 filing 424B3
- 2025-05-19 filing EFFECT
- 2025-05-15 filing CORRESP
- 2025-05-15 filing UPLOAD
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-13 filing EFFECT
- 2025-05-12 filing Registration (S-1)
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing POS AM
- 2025-05-12 filing Quarterly report (10-Q)
- 2025-05-12 filing 8-K items 2.02,9.01
- 2025-04-17 filing SCHEDULE 13D
- 2025-04-16 filing 8-K items 1.02,2.02,5.01,7.01,8.01,9.01
- 2025-04-14 filing SCHEDULE 13D/A
- 2025-04-11 filing 8-K items 1.01,9.01
- 2025-03-06 filing Annual report (10-K)
- 2025-03-06 filing 8-K items 2.02,9.01
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-12 filing 8-K items 2.02,9.01
- 2024-09-11 filing EFFECT
- 2024-09-11 filing 424B3
- 2024-09-10 filing SC 13D/A
- 2024-09-09 filing EFFECT
- 2024-09-09 filing CORRESP
- 2024-09-09 filing UPLOAD
- 2024-09-04 filing POS AM
- 2024-09-03 filing S-3
- 2024-09-03 filing 8-K items 8.01,9.01
- 2024-08-12 filing D
- 2024-08-08 filing 8-K items 1.01,3.02,8.01,9.01
- 2024-08-08 filing Quarterly report (10-Q)
- 2024-08-08 filing 8-K items 2.02,9.01
- 2024-07-24 filing 8-K items 5.07
- 2024-06-10 filing ARS
- 2024-06-10 filing Proxy statement
- 2024-05-15 filing Quarterly report (10-Q)
- 2024-05-15 filing 8-K items 2.02,9.01
- 2024-04-08 filing EFFECT
- 2024-04-04 filing CORRESP
- 2024-04-02 filing UPLOAD
- 2024-04-01 filing S-3
- 2024-04-01 filing Annual report (10-K)
- 2024-04-01 filing 8-K items 2.02,9.01
- 2024-03-07 filing 8-K items 1.01,2.03,7.01,9.01
- 2023-11-14 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,9.01
- 2023-10-26 filing 8-K/A items 9.01
- 2023-10-23 filing 8-K items 7.01,8.01,9.01
- 2023-08-18 filing 8-K items 4.01,9.01
- 2023-08-10 filing 8-K items 1.01,2.01,7.01,9.01
- 2023-08-09 filing 8-K items 8.01
- 2023-08-03 filing SC 13D/A
- 2023-08-01 filing Quarterly report (10-Q)
- 2023-08-01 filing 8-K items 2.02,9.01
- 2023-07-28 filing S-8
- 2023-07-28 filing S-8 POS
- 2023-07-28 filing S-8 POS
- 2023-07-28 filing S-8 POS
- 2023-07-28 filing S-8 POS
- 2023-07-28 filing 8-K items 7.01,9.01
- 2023-07-28 officer change 8-K items 5.02,5.03,5.07,9.01
- 2023-07-14 filing 424B3
- 2023-07-13 filing EFFECT
- 2023-07-12 filing D
- 2023-07-11 filing CORRESP
- 2023-07-11 filing S-3/A
- 2023-07-11 filing 8-K items 1.01,9.01
- 2023-07-10 filing UPLOAD
- 2023-07-07 filing S-3
- 2023-07-03 filing 8-K items 1.01,2.02,3.02,7.01,8.01,9.01
- 2023-06-20 filing 8-K items 1.01,9.01
- 2023-06-08 filing ARS
- 2023-06-08 filing Proxy statement
- 2023-05-19 filing PRE 14A
- 2023-05-19 filing 8-K items 5.03,9.01
- 2023-05-18 officer change 8-K items 5.02,7.01,9.01
- 2023-05-16 filing 8-K/A items 9.01
- 2023-05-05 filing SC 13D/A
- 2023-05-04 filing Quarterly report (10-Q)
- 2023-05-04 filing 8-K items 2.02,9.01
- 2023-05-04 officer change 8-K items 5.02,9.01
- 2023-03-07 filing Annual report (10-K)
- 2023-03-07 filing 8-K items 2.02,9.01
- 2023-03-01 filing 8-K items 1.01,2.01,2.03,7.01,9.01
- 2023-02-01 filing 8-K items 8.01
- 2023-01-09 officer change 8-K items 5.02,7.01,9.01
- 2022-11-03 filing Quarterly report (10-Q)
- 2022-11-03 filing 8-K items 2.02,9.01
- 2022-10-28 filing S-8
- 2022-10-28 officer change 8-K items 5.02,5.07,9.01
- 2022-10-20 filing EFFECT
- 2022-10-20 filing 424B3
- 2022-10-18 filing CORRESP
- 2022-10-17 filing UPLOAD
- 2022-10-11 filing S-3
- 2022-10-11 filing 8-K items 3.02,7.01,9.01
- 2022-09-20 filing Proxy statement
- 2022-09-09 filing DEF 14C
- 2022-09-06 filing SC 13D
- 2022-08-31 officer change 8-K items 3.02,5.02,7.01,8.01,9.01
- 2022-08-30 filing SC 13D/A
- 2022-08-30 filing PRE 14C
- 2022-08-26 filing D
- 2022-08-24 officer change 8-K items 1.01,3.02,5.02,8.01,9.01
- 2022-08-04 filing Quarterly report (10-Q)
- 2022-08-04 filing 8-K items 2.02,9.01
- 2022-05-05 filing Quarterly report (10-Q)
- 2022-05-05 filing 8-K items 2.02,9.01
- 2022-05-02 officer change 8-K items 5.02,9.01
- 2022-03-08 filing 8-A12B/A
- 2022-03-08 filing Annual report (10-K)
- 2022-03-08 filing 8-K items 2.02,9.01
- 2022-01-03 officer change 8-K items 5.02,7.01,9.01
- 2021-11-12 filing Quarterly report (10-Q)
- 2021-11-12 filing 8-K items 2.02,9.01
- 2021-08-05 filing Quarterly report (10-Q)
- 2021-08-05 filing 8-K items 2.02,9.01
- 2021-07-28 filing 8-K items 5.07
- 2021-06-14 filing Proxy statement
- 2021-05-20 filing 8-K items 7.01,9.01
- 2021-05-18 filing EFFECT
- 2021-05-14 filing CORRESP
- 2021-05-14 filing UPLOAD
- 2021-05-11 filing Quarterly report (10-Q)
- 2021-05-11 filing 8-K items 2.02,8.01,9.01
- 2021-05-11 filing S-3
- 2021-05-06 filing 8-K items 1.01,1.02,2.03,9.01
- 2021-04-15 filing 424B3
- 2021-04-14 filing EFFECT
- 2021-04-12 filing CORRESP
- 2021-04-09 filing UPLOAD
- 2021-04-09 filing SC 13D/A
- 2021-04-06 filing S-3
- 2021-03-03 filing EFFECT
- 2021-02-26 filing D
- 2021-02-26 filing SC 13D/A
- 2021-02-24 filing POS AM
- 2021-02-24 filing Annual report (10-K)
- 2021-02-24 filing 8-K items 2.02,9.01
- 2021-02-22 filing 8-K items 1.01,3.02,8.01,9.01
- 2020-12-23 filing EFFECT
- 2020-12-22 filing CORRESP
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) 10-Q filed
- 2026-11-16 (within 7 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-11 (older) 10-Q filed
- 2026-08-11 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-07 (older) 8-K filed: Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-06-23 (older) ARS filed
- 2026-06-23 (older) DEFA14A filed
- 2026-06-23 (older) DEF 14A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NYSE:XTNT The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1453593 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | XTNT / NYSE | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 549300JOU6AK8387EW77 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 549300JOU6AK8387EW77) | GLEIF |
| EIN | 205313323 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001453593 | SEC EDGAR / IRS |
| CUSIP | 98420P308 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001453593 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $133,927,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-22 03:32 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $4,973,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 03:32 UTC | Report an error |
| Total assets (at 2025-12-31) | $94,145,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 03:32 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $50,953,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 03:32 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $17,053,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 03:32 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
| Business address | 664 CRUISER LANE, BELGRADE, MT, 59714 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
| Exchanges | NYSE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-22 03:32 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $12,546,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 03:32 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $2,382,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-22 03:32 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $11,026,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-22 03:32 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $3,287,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 03:32 UTC | Report an error |
| Form D total offering amount (D filed 2024-08-12) | $5,000,000 | 2024-08-12 | D | as filed | 2026-11-22 03:32 UTC | Report an error |
| Form D total amount sold (D filed 2024-08-12) | $5,000,000 | 2024-08-12 | D | as filed | 2026-11-22 03:32 UTC | Report an error |
| Form D industry group | Other Health Care | 2024-08-12 | D | as filed | 2026-11-22 03:32 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2024-08-12 | D | as filed | 2026-11-22 03:32 UTC | Report an error |
| Form D date of first sale | 2024-08-09 | 2024-08-12 | D | as filed | 2026-11-22 03:32 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001493152-26-052000
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $24,285,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052000 | 2026-11-22 03:32 UTC | Report an error |
| Net income (loss) | -$3,562,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052000 | 2026-11-22 03:32 UTC | Report an error |
| Interest expense | $590,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052000 | 2026-11-22 03:32 UTC | Report an error |
| Cash and cash equivalents | $7,793,000 | at 2026-09-30 | 10-Q | 2026-11-16 | 0001493152-26-052000 | 2026-11-22 03:32 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing 10-Q filed
- 2026-11-16 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-07 Filing 8-K filed: Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-06-23 Filing ARS filed
- 2026-06-23 Filing DEFA14A filed
- 2026-06-23 Filing DEF 14A filed
- 2026-05-29 Filing SD filed
- 2026-05-13 Filing S-8 POS filed
- 2026-05-13 Filing S-8 POS filed
- 2026-05-13 Filing S-8 POS filed
- 2026-05-13 Filing S-8 POS filed
- 2026-05-13 Filing 10-Q filed
- 2026-05-13 Filing 8-K filed: Item 2.02 results of operations; Item 8.01 other event; Item 9.01 exhibits
- 2026-04-13 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2026-03-31 Filing 10-K filed
- 2026-03-31 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-03-02 Filing 8-K filed: Item 8.01 other event
- 2026-01-16 Filing 8-K filed: Item 8.01 other event
- 2025-12-03 Filing 8-K filed: Item 2.01 acquisition or disposition; Item 2.04; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-10 Filing S-8 filed
- 2025-11-10 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-11-10 Filing 10-Q filed
- 2025-11-10 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
8-K item text, as filed (excerpts)
- 2026-08-11 8-K Item 2.02
Results of Operations and Financial Condition. On August 11, 2026, Xtant Medical Holdings, Inc. (the “Company”) announced its financial results for the second quarter of 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Item 2.02 of this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration statement or other document filed by the Company under… the 8-K · retrieved 2026-11-22 03:32 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | $57,587,748 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 2 | AWM Investment Company, Inc. | $2,516,279 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $848,148 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $393,685 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $217,773 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 6 | Crescent Grove Advisors, LLC | $173,462 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 7 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | $168,400 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 8 | VANGUARD FIDUCIARY TRUST CO | $108,613 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 9 | CITADEL ADVISORS LLC | $80,566 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
| 10 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $69,086 | 2026-06-30 | SEC 13F filing | 2026-11-22 03:32 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Xtant Medical Holdings, Inc. · LEI 549300JOU6AK8387EW77 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
USAspending (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchXTANT MEDICAL HOLDINGS, INC. · exact legal name · sx:usaspending:JN7YZJBMVPD4 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1453593.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001453593. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.